Hormone therapy, after the scare
A generation of women were taken off hormone therapy almost overnight, on the strength of one alarming headline. The evidence has been read more carefully since. Here is the calm version.
If you were told, or half-remember being told, that hormone therapy causes breast cancer and is simply too risky, you are carrying the aftershock of the summer of 2002. That is when the first results of a very large trial were announced in a way that frightened women and doctors alike. Prescriptions collapsed. Two decades later, the picture is more measured, and worth understanding before you decide anything.
What actually happened in 2002
The trial in question studied one specific formulation, in women whose average age was well past menopause — many in their sixties. The early headline reported a relative increase in risk that sounded enormous, without the context that the absolute risk to any individual woman was small, and that the group studied was not the group most doctors treat now: women in their forties and fifties, close to the transition, with disruptive symptoms. Later re-analyses, and the reading laid out by Avrum Bluming and Carol Tavris in Estrogen Matters, argue that the benefits were understated and the risks overstated for younger women — and that the blanket retreat did real harm of its own.
Where the mainstream sits today
You do not have to take a contrarian book’s word for it. The Menopause Society — the main professional body in this field — states in its 2022 position statement that for healthy women under about sixty, or within roughly ten years of their last period, the benefits of hormone therapy generally outweigh the risks when it is used for bothersome symptoms. It remains the most effective treatment for hot flashes and night sweats, it helps protect bone, and it treats the genital and urinary changes covered in dryness, discomfort, and GSM.
This is not a sales pitch for hormones. They are not right for everyone, the risks are real and individual, and the decision belongs with you and a clinician who knows your history. The point is only that “absolutely not, it causes cancer” is not where the evidence has landed — and you are allowed to ask.
How to raise it without being brushed off
- Ask directly whether hormone therapy is an option for you, and if not, why not, in terms of your specific history rather than a general policy.
- Bring the changes that are actually costing you sleep, focus or comfort — the concrete ones, written down.
- If the first answer is a reflexive no, it is reasonable to ask for the reasoning or a second opinion. Jen Gunter’s The Menopause Manifesto is good on the difference between a considered no and an out-of-date one.
How Still Me helps
Still Me will not tell you whether to take hormones — that is a medical decision, and it says so plainly. What it will do is help you walk in prepared. The doctor-prep session interviews you and writes a single page: what is happening, since when, how often, and the questions worth asking, including the direct one about hormone therapy. If you have been quietly talked out of asking before, see when you’re told it’s stress and talking to your doctor.
Grounded in Avrum Bluming & Carol Tavris, Estrogen Matters; The Menopause Society’s 2022 Hormone Therapy Position Statement; and Jen Gunter, The Menopause Manifesto.
This is general information, not medical advice, and Still Me does not diagnose or prescribe. For anything about your own body or treatment, talk to a clinician. If you feel unsafe, contact your local emergency service.